Skip to content

Clinical trials

Completed Epilepsies, Myoclonic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Myoclonic Status: Completed Country / region: Australia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20162
20181
20191
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Longboard Pharmaceuticals2
Takeda2
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2
Jazz Pharmaceuticals1
Zogenix, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Myoclonic8
Epilepsy6
Lennox Gastaut Syndrome4
Brain Diseases3
Seizures3
Tuberous Sclerosis3
Central Nervous System Diseases1
Hypoxia-Ischemia, Brain1
Malformations of Cortical Development1
Nervous System Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.